206 related articles for article (PubMed ID: 22379198)
21. Prevalence of serum antibody titers against canine distemper virus and canine parvovirus in dogs hospitalized in an intensive care unit.
Mahon JL; Rozanski EA; Paul AL
J Am Vet Med Assoc; 2017 Jun; 250(12):1413-1418. PubMed ID: 28569640
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of viral pathogens of free-ranging dogs and Indian foxes in a human-dominated landscape in central India.
Belsare AV; Vanak AT; Gompper ME
Transbound Emerg Dis; 2014 Aug; 61 Suppl 1():78-86. PubMed ID: 25135467
[TBL] [Abstract][Full Text] [Related]
24. Assessing demographic and epidemiologic parameters of rural dog populations in India during mass vaccination campaigns.
Belsare AV; Gompper ME
Prev Vet Med; 2013 Aug; 111(1-2):139-46. PubMed ID: 23664490
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of a point-of-care ELISA test kit for predicting the presence of protective canine parvovirus and canine distemper virus antibody concentrations in dogs.
Litster AL; Pressler B; Volpe A; Dubovi E
Vet J; 2012 Aug; 193(2):363-6. PubMed ID: 22381707
[TBL] [Abstract][Full Text] [Related]
26. Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit.
Killey R; Mynors C; Pearce R; Nell A; Prentis A; Day MJ
J Small Anim Pract; 2018 Jan; 59(1):27-31. PubMed ID: 29087557
[TBL] [Abstract][Full Text] [Related]
27. Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs.
Henry CJ; McCaw DL; Brock KV; Stoker AM; Tyler JW; Tate DJ; Higginbotham ML
J Am Vet Med Assoc; 2001 Nov; 219(9):1238-41. PubMed ID: 11697366
[TBL] [Abstract][Full Text] [Related]
28. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
[TBL] [Abstract][Full Text] [Related]
29. Comparison of immunity against canine distemper, adenovirus and parvovirus after vaccination with two multivalent canine vaccines.
Cunha RDS; da Silva Junior CL; Costa CA; de Aguiar HM; Junqueira Júnior DG
Vet Med Sci; 2020 Aug; 6(3):330-334. PubMed ID: 32338828
[TBL] [Abstract][Full Text] [Related]
30. A point-of-care dot blot ELISA assay for detection of protective antibody against canine adenovirus, canine parvovirus, and canine distemper virus is diagnostically accurate.
Egerer A; Schaefer Z; Larson L
J Am Vet Med Assoc; 2022 Oct; 260(15):1928-1933. PubMed ID: 36198054
[TBL] [Abstract][Full Text] [Related]
31. Serologic survey for canine distemper virus and canine parvovirus in free-ranging wild carnivores from Portugal.
Santos N; Almendra C; Tavares L
J Wildl Dis; 2009 Jan; 45(1):221-6. PubMed ID: 19204354
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibodies to canine parvovirus and distemper virus in wolves in the Canadian Rocky Mountains.
Nelson B; Hebblewhite M; Ezenwa V; Shury T; Merrill EH; Paquet PC; Schmiegelow F; Seip D; Skinner G; Webb N
J Wildl Dis; 2012 Jan; 48(1):68-76. PubMed ID: 22247375
[TBL] [Abstract][Full Text] [Related]
33. High Prevalence of Antibodies against Canine Parvovirus and Canine Distemper Virus among Coyotes and Foxes from Pennsylvania: Implications for the Intersection of Companion Animals and Wildlife.
Kimpston CN; Hatke AL; Castelli B; Otto N; Tiffin HS; Machtinger ET; Brown JD; Van Why KR; Marconi RT
Microbiol Spectr; 2022 Feb; 10(1):e0253221. PubMed ID: 35080421
[No Abstract] [Full Text] [Related]
34. Epidemiology of canine distemper and canine parvovirus in domestic dogs in urban and rural areas of the Araucanía region in Chile.
Acosta-Jamett G; Surot D; Cortés M; Marambio V; Valenzuela C; Vallverdu A; Ward MP
Vet Microbiol; 2015 Aug; 178(3-4):260-4. PubMed ID: 26013417
[TBL] [Abstract][Full Text] [Related]
35. Serosurvey for CPV-2, distemper virus, ehrlichiosis and leishmaniosis in free-ranging dogs in Italy.
Corrain R; Di Francesco A; Bolognini M; Ciucci P; Baldelli R; Guberti V
Vet Rec; 2007 Jan; 160(3):91-2. PubMed ID: 17237459
[No Abstract] [Full Text] [Related]
36. Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.
Böhm M; Thompson H; Weir A; Hasted AM; Maxwell NS; Herrtage ME
Vet Rec; 2004 Apr; 154(15):457-63. PubMed ID: 15119729
[TBL] [Abstract][Full Text] [Related]
37. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
Olson P; Klingeborn B; Hedhammar A
Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
[TBL] [Abstract][Full Text] [Related]
38. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
39. Clinical assessment of a point-of-care assay to determine protective vaccinal antibody titers to canine viral diseases.
Ad Y; Halperin IM; Olstad EC; Gershwin LJ; Sullivan L; Reagan KL
Vet J; 2023; 298-299():106017. PubMed ID: 37524148
[TBL] [Abstract][Full Text] [Related]
40. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
